Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Anchor Capital Advisors LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 119,274 shares of the medical research company’s stock after selling 5,308 shares […]
By Chris Wack Inotiv shares were up 22% to $4.50 after the company reported a first-quarter loss that was less than analysts' expectations. The contract...
Bryn Mawr Capital Management LLC cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,809 shares of the medical research company’s stock after […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 […]
Zions Bancorporation N.A. raised its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 28.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,727 shares of the medical research company’s stock after buying an additional 1,473 shares during the quarter. […]